Durable Mechanical Circulatory Support: JACC Scientific Statement

RJ Tedford, M Leacche, A Lorts, SG Drakos… - Journal of the American …, 2023 - jacc.org
Despite advances in medical therapy for patients with stage C heart failure (HF), survival for
patients with advanced HF is< 20% at 5 years. Durable left ventricular assist device (dLVAD) …

Fifth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report

JW Rossano, CJ VanderPluym, DM Peng… - The Annals of thoracic …, 2021 - Elsevier
Abstract Background The Pediatric Interagency Registry for Mechanical Circulatory Support
(Pedimacs) provides detailed information on pediatric patients supported with ventricular …

[HTML][HTML] Pediatric ventricular assist device registries: update and perspectives in the era of miniaturized continuous-flow pumps

KM Lichtenstein, HP Tunuguntla, DM Peng… - Annals of …, 2021 - ncbi.nlm.nih.gov
The success of ventricular assist devices (VADs) in the treatment of end-stage heart failure
in the adult population has led to industrial innovation in VAD design, focusing on …

Third annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: preimplant characteristics and outcomes

DLS Morales, JW Rossano, C VanderPluym… - The Annals of thoracic …, 2019 - Elsevier
Background The influence of ventricular assist device (VAD) use in the care of children with
end-stage heart failure is growing rapidly through increasing numbers, new devices …

Berlin Heart EXCOR and ACTION post-approval surveillance study report

F Zafar, J Conway, MS Bleiweis, M Al-Aklabi… - The Journal of Heart and …, 2021 - Elsevier
BACKGROUND The Berlin Heart EXCOR Pediatric (EXCOR) ventricular assist device (VAD)
was introduced in North America nearly 2 decades ago. The EXCOR was approved under …

The creation of a pediatric health care learning network: the ACTION quality improvement collaborative

A Lorts, L Smyth, RJ Gajarski, CJ VanderPluym… - Asaio …, 2020 - journals.lww.com
Improving the outcomes of pediatric patients with congenital heart disease with end-stage
heart failure depends on the collaboration of all stakeholders; this includes providers …

JCS/JSCVS/JATS/JSVS 2021 Guideline on implantable left ventricular assist device for patients with advanced heart failure

M Ono, O Yamaguchi, T Ohtani, K Kinugawa… - Circulation …, 2022 - jstage.jst.go.jp
1. Background More than 20 years have passed since heart transplantation began to be
performed under the Organ Transplant Law enacted in 1997. The Law was amended to …

ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the …

A Lorts, J Conway, M Schweiger, I Adachi… - The Journal of Heart …, 2021 - jhltonline.org
Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …

Mechanical support for the failing single ventricle at pre-Fontan stage: current state of the field and future directions

K Puri, I Adachi - Seminars in Thoracic and Cardiovascular Surgery …, 2021 - Elsevier
With the substantial growth of pediatric ventricular assist device (VAD) support, there has
been an expansion of the target population towards more complex patients, including …

Waitlist outcomes for children with congenital heart disease: lessons learned from over 5000 heart transplant listings in the United States

M Townsend, T Karamlou, G Boyle, K Daly… - Journal of cardiac …, 2022 - Elsevier
Background We evaluated the impact of pediatric heart-allocation policy changes over time
and the approval of the Berlin ventricular assist device (VAD) on waitlist (WL) outcomes for …